IL18 and macrophage activation syndrome: More important, the administration of recombinant human IL-18 binding protein (rhIL-18BP), a natural IL-18 inhibitor, successfully treated a child with recurrent episodes of severe MAS (7), indicating that IL-18 is pathogenic in this condition.